Loading...
Loading...
8. Aug 24
8. Aug 24
6. Aug 24
2. Aug 24
31. Jul 24
9. Aug 24
7. Aug 24
7. Aug 24
6. Aug 24
6. Aug 24
On February 1st, after Ardelyx spent $340k lobbying Congress on issues related to Medicare ESRD benefits & chronic kidney disease management, our Lobbying Spending Growth Strategy went long on $ARDX. The stock has soared nearly 55% since.